The survival of this niche depends on the chemokine-dependent CXCL12-CXCR4 ligand-receptor signaling axis, where CAF-derived CXCL12 binds to CXCR4 on tumor cells, fostering a tumor-promoting niche that suppresses ferroptosis and promotes survival. Here, CXCL12 is linked to neoplasm.